Department of Basic and Clinical Neuroscience, King's College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, 5 Cutcombe Road, London, SE5 9RX, UK.
Department of Molecular Neuroscience, Institute of Neurology, University College London, Queen's Square, London, WC1N, 3BG, UK.
Acta Neuropathol Commun. 2017 Oct 17;5(1):74. doi: 10.1186/s40478-017-0476-y.
The neuronal ceroid lipofuscinoses (NCLs or Batten disease) are a group of inherited, fatal neurodegenerative disorders of childhood. In these disorders, glial (microglial and astrocyte) activation typically occurs early in disease progression and predicts where neuron loss subsequently occurs. We have found that in the most common juvenile form of NCL (CLN3 disease or JNCL) this glial response is less pronounced in both mouse models and human autopsy material, with the morphological transformation of both astrocytes and microglia severely attenuated or delayed. To investigate their properties, we isolated glia and neurons from Cln3-deficient mice and studied their basic biology in culture. Upon stimulation, both Cln3-deficient astrocytes and microglia also showed an attenuated ability to transform morphologically, and an altered protein secretion profile. These defects were more pronounced in astrocytes, including the reduced secretion of a range of neuroprotective factors, mitogens, chemokines and cytokines, in addition to impaired calcium signalling and glutamate clearance. Cln3-deficient neurons also displayed an abnormal organization of their neurites. Most importantly, using a co-culture system, Cln3-deficient astrocytes and microglia had a negative impact on the survival and morphology of both Cln3-deficient and wildtype neurons, but these effects were largely reversed by growing mutant neurons with healthy glia. These data provide evidence that CLN3 disease astrocytes are functionally compromised. Together with microglia, they may play an active role in neuron loss in this disorder and can be considered as potential targets for therapeutic interventions.
神经元蜡样质脂褐质沉积症(NCLs 或 Batten 病)是一组遗传性、致命的儿童神经退行性疾病。在这些疾病中,神经胶质(小胶质细胞和星形胶质细胞)激活通常在疾病进展的早期发生,并预测随后神经元丢失的位置。我们发现,在最常见的青少年型 NCL(CLN3 病或 JNCL)中,这种神经胶质反应在小鼠模型和人类尸检材料中都不那么明显,星形胶质细胞和小胶质细胞的形态转化严重减弱或延迟。为了研究它们的特性,我们从小鼠的 Cln3 缺陷中分离出神经胶质和神经元,并在培养物中研究它们的基本生物学特性。在受到刺激时,Cln3 缺陷型星形胶质细胞和小胶质细胞的形态转化能力也减弱,并且其蛋白质分泌谱发生改变。这些缺陷在星形胶质细胞中更为明显,包括一系列神经保护因子、有丝分裂原、趋化因子和细胞因子的分泌减少,以及钙信号和谷氨酸清除功能受损。Cln3 缺陷型神经元的神经突也表现出异常的组织排列。最重要的是,使用共培养系统,Cln3 缺陷型星形胶质细胞和小胶质细胞对 Cln3 缺陷型和野生型神经元的存活和形态都有负面影响,但通过用健康的神经胶质细胞培养突变神经元,这些影响在很大程度上得到了逆转。这些数据提供了证据表明 CLN3 病星形胶质细胞的功能受损。与小胶质细胞一起,它们可能在该疾病的神经元丢失中发挥积极作用,并可被视为潜在的治疗干预靶点。